| Datum | Zeit | Quelle | Überschrift | Symbol | Firma |
| 14/02/2014 | 21h15 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 10/10/2013 | 21h54 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 23/09/2013 | 15h35 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 17/09/2013 | 12h00 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 17/09/2013 | 12h00 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 14/09/2013 | 00h25 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 14/09/2013 | 00h24 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 14/09/2013 | 00h23 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 14/09/2013 | 00h22 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 14/09/2013 | 00h20 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 14/09/2013 | 00h20 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 13/09/2013 | 22h03 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 13/09/2013 | 22h03 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 13/09/2013 | 22h02 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 13/09/2013 | 22h02 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 13/09/2013 | 22h02 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 13/09/2013 | 22h02 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 13/09/2013 | 22h02 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 13/09/2013 | 22h01 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 11/09/2013 | 23h11 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 11/09/2013 | 23h10 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 11/09/2013 | 23h08 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 11/09/2013 | 22h30 | Business Wire | Cubist Pharmaceuticals Completes Acquisition of Trius Therapeutics | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 11/09/2013 | 22h30 | Business Wire | Cubist Pharmaceuticals Completes Acquisition of Trius Therapeutics | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 11/09/2013 | 22h26 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 11/09/2013 | 17h00 | Business Wire | Cubist Pharmaceuticals Announces Results of Tender Offer for Outstanding Shares of Trius Therapeutics | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 11/09/2013 | 17h00 | Business Wire | Cubist Pharmaceuticals Announces Results of Tender Offer for Outstanding Shares of Trius Therapeutics | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 06/09/2013 | 22h01 | GlobeNewswire Inc. | Trius Therapeutics to Present Data From Antibiotics Development Programs at ICAAC 2013 | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 05/09/2013 | 22h51 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 05/09/2013 | 22h46 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |